navigation
We would like to thank the following companies for their financial support to the SHCS.
ranking for the funding over the last 5 years
Gilead Sciences Switzerland Sàrl
General-Guisan-Strasse 8
6300 Zug
ViiV Healthcare
Talstrasse 3-5
3053 Münchenbuchsee
MSD Merck Sharp & Dohme AG
Werftestrasse 4
6005 Luzern
The Swiss HIV Cohort Study (SHCS), established in 1988, is a nationwide prospective longitudinal cohort study enrolling persons with HIV in Switzerland. It is a collaboration of all Swiss university hospitals, large cantonal hospitals with affiliated laboratories, and affiliated smaller hospitals and private physicians caring for persons with HIV.
The overarching aim of the SHCS is to improve health of persons living with HIV through clinical, translational and basic science studies, and to strengthen collaborative and transdisciplinary research.
The Swiss Mother and Child HIV Cohort Study (MoCHiV) is integrated into the SHCS. It aims at preventing mother-to-child transmission and enrolls pregnant women with HIV and their children.
If you spot a bug or have a suggestion, let us know:
What happened? (Details help!)
What device are you using?
Screenshot? (Optional but helpful)
Your feedback goes straight to the SHCS dev team and helps us improve faster.
Thanks for making the SHCS website better!